2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Toxicity: new trials by email Literature Review of Toxicity trials Research Report on Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning Alpha Lipoic Acid (Thioctacid), Placebo (for Alpha Lipoic Acid) - Toxicity | Phase 2 | Unknown | Heba Allah Ali Abd El-Halim Mabrouk | 50 | 2016-05-01 | 2016-05-10 |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients Gefitinib, Pemetrexed, Cisplatin or carboplatin - Toxicity, Non-small Cell Lung Cancer | Phase 2 | Unknown | Fudan University | 68 | 2009-12-01 | 2010-09-03 |
Carcinoma, Non-Small-Cell Lung (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Carboplatin (1) · Cisplatin (1) · Gefitinib (1) · Pemetrexed (1) · Thioctic Acid (1)
Fudan University (1) · Heba Allah Ali Abd El-Halim Mabrouk (1)
China (1)